Resonance Specialties Ltd

Resonance Specialties Limited will hold a board meeting on Friday, October 30, 2026, to consider and approve the unaudited financial results for the second quarter and half year ended September 30, 2026, according to a regulatory filing with the BSE Ltd. The trading window for company insiders will remain closed from the end of business hours on September 30, 2026, until 48 hours after the financial results are declared.

Resonance Specialties Limited submitted a certificate to the BSE Ltd. on October 3, 2026, confirming compliance with Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, as certified by Adroit Corporate Services Private Limited, the company’s Registrar and share Transfer Agent, for the quarter ended September 30, 2026.

Resonance Specialties Limited informed the BSE Ltd. that the trading window for dealings in the company's securities by insiders will be closed from the close of business hours on September 30, 2026, and will remain closed until 48 hours after the declaration of the company’s unaudited financial results for the second quarter and half year ended September 30, 2026, of the financial year 2026-27.

Resonance Specialities Ltd announced on August 26, 2026, that CRISIL has reaffirmed the credit ratings for its financial facilities, specifically Total Bank Loan Facilities amounting to Rs 14 Crore, carrying a Long-Term Rating of CRISIL BBB-/Stable; the rating also applies to Proposed Fund-Based Bank Limits of Rs 2 Crore and a Working Capital Facility of Rs 12 Crore; there are no enhancements, assignments, or withdrawals related to these ratings, and the reaffirmation pertains solely to the instruments as listed.

Resonance Specialities will hold a meeting of the Board of Directors of the Company on 4 August 2026.

Resonance Specialities announced that the 37th Annual General Meeting(AGM) of the company will be held on 4 August 2026.

Resonance Specialities announced that the Board of Directors of the Company at its meeting held on 14 May 2026, inter alia, have recommended the final dividend of Rs 1 per equity Share (i.e. 10%) , subject to the approval of the shareholders.

Net profit of Resonance Specialities rose 50.33% to Rs 4.60 crore in the quarter ended March 2026 as against Rs 3.06 crore during the previous quarter ended March 2025. Sales rose 1.16% to Rs 24.48 crore in the quarter ended March 2026 as against Rs 24.20 crore during the previous quarter ended March 2025. For the full year,net profit rose 58.30% to Rs 10.40 crore in the year ended March 2026 as against Rs 6.57 crore during the previous year ended March 2025. Sales rose 15.99% to Rs 90.25 crore in the year ended March 2026 as against Rs 77.81 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales24.4824.20 1 90.2577.81 16 OPM %23.0817.56 -15.5313.64 - PBDT6.344.31 47 15.4211.24 37 PBT6.004.20 43 14.089.68 45 NP4.603.06 50 10.406.57 58 Powered by Capital Market - Live

Resonance Specialities will hold a meeting of the Board of Directors of the Company on 14 May 2026.

Net profit of Resonance Specialities rose 124.11% to Rs 2.51 crore in the quarter ended December 2025 as against Rs 1.12 crore during the previous quarter ended December 2024. Sales rose 25.88% to Rs 22.96 crore in the quarter ended December 2025 as against Rs 18.24 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales22.9618.24 26 OPM %15.0710.42 - PBDT3.732.12 76 PBT3.391.64 107 NP2.511.12 124 Powered by Capital Market - Live